| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,085 | 0,094 | 02.04. | |
| 0,078 | 0,090 | 02.04. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 1.100,00 | 10.000 | |||
| 0,700 | 1.000 | |||
| 0,138 | 5.000 | |||
| 0,114 | 95.859 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/psh0.htm [/URL] | ||||
| 95.859 | 0,078 | |||
| 17.676 | 0,071 | |||
| 1.007 | 0,001 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 114.542 | 0,977 | 111.859 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 01.04.2026 | 09:04:40 | 0,093 | 2.599 |
| Tagesumsatz Xetra | 0,000 0,00 % | 440 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.03. | Sernova Biotherapeutics Inc: Sernova closes $2.1-million private placement | 38 | Stockwatch | ||
| 24.03. | Stocks in Play: Sernova Biotherapeutics | 26 | Baystreet.ca | ||
| 24.03. | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing | 290 | Newsfile | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 24, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC Pink: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 18.03. | Sernova Biotherapeutics Inc: Sernova says Swetlow fired over trip, improper payouts | 47 | Stockwatch | ||
| 04.03. | Sernova Biotherapeutics Inc: Sernova arranges $7.1-million in financings | 43 | Stockwatch |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Do | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| Do | Gegen den Ärztemangel: Asklepios und MSH schaffen zusätzliche Medizinstudienplätze in Hamburg | news aktuell | Hamburg (ots) - Die Asklepios Kliniken Gruppe und die MSH Medical School Hamburg - University of Applied Sciences and Medical University (MSH) bündeln ihre Kräfte, um dem steigenden Bedarf an qualifizierten... ► Artikel lesen | |
| Do | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| Do | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| Do | Carl Zeiss Meditec AG: ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS | PR Newswire | Photo - https://mma.prnewswire.com/media/2948690/ZEISS_Collaborative_Care.jpgPhoto - https://mma.prnewswire.com/media/2948691/ZEISS_IOLMaster_700.jpgPhoto - https://mma.prnewswire.com/media/2948692/ZEISS_VERACITY_Surgery_Planner.jpgPhoto... ► Artikel lesen |